Cerianna is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) imaging for the detection of ER+ lesions as an adjunct to biopsy in patient with recurrent or metastatic breast cancer.
GE Healthcare helps clinicians provide the best patient care possible. As a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions. We are committed to fostering an inclusive culture of respect, transparency, and unyielding integrity.
Additional Info
Will your company display a new product or promote a new indication/enhanced feature(s) for an existing product in your booth?
Yes